MedTrace Logo

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

NCT02438904 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-20

No results posted yet for this study

Summary

Objectives:

Primary Objective

To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Conditions

  • Blood And Marrow Transplantation

Interventions

BIOLOGICAL

CD34 Positive Stem Cell Infusion

Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells.

DEVICE

Miltenyi device

Miltenyi device is used for CD34+ cell infusions) to patients who experience poor graft function after stem cell transplantation (SCT).

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Elizabeth Shpall, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-06
Primary Completion
2027-05-01
Completion
2027-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438904 on ClinicalTrials.gov